UK Drops $8M into Synthetic Bio Business Projects | GenomeWeb

NEW YORK (GenomeWeb News) – As part of a new push to become a leading player in synthetic biology, the UK has provided £5.3 million ($8 million) to fund 15 new synthetic biology technology development projects at a number of companies.

The funding will fuel an array of tech development efforts at about a dozen companies. The grant winners were chosen through a competition for projects that will be led by businesses seeking to demonstrate the feasibility of using synthetic biology to create new products and processes or improve older ones.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.